SAGILITY LIMITED
NSE: SAGILITYINE0W2G01015·Information TechnologySmallcap 250·www.sagilityhealth.com ↗·Mcap ₹21,520 Cr·Listed 2024
₹44.69▼ ₹0.31  (−0.69%)
52W: ₹36 – ₹58 · Vol: 96.2L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q2 FY25
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25
Revenue from operations1,9632,0241,9711,6581,5391,5681,4531,325
Other income14.324.88.458.29.910.14415.3
Total expenses1,6751,6861,6081,3901,3381,3401,2071,180
EBITDA438485511415346373392301
EBITDA margin22.3%23.9%25.9%25.0%22.5%23.8%27.0%22.7%
Finance costs21.922.124.72527.429.830.229.7
Depreciation128124124122118114116126
Profit before tax287363339327210239290160
Tax70.710570.97661.856.472.943.1
Net profit217258268251149183217117
Net margin11.0%12.7%13.6%15.1%9.7%11.6%14.9%8.9%
EPS (₹)0.460.560.570.530.320.390.460.25
Net profit YoY+45.9%+41.2%+23.4%+113.8%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25
Revenue from operations7,1935,570
Other income9856.3
Total expenses6,0194,866
EBITDA1,7601,298
EBITDA margin24.5%23.3%
Finance costs99.2127
Depreciation487467
Profit before tax1,239760
Tax314221
Net profit925539
Net margin12.9%9.7%
EPS (₹)1.981.17
Net profit YoY+71.5%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25
Operating cash flow1,2031,214
Investing cash flow−711−964
Financing cash flow−501−256
Capital expenditure192124
Free cash flow (CFO − capex)1,0111,090

Net profit trend

annual, ₹ crore
FY25
₹539
FY26
₹925+72%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated21 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone21 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated12 May 2026PDF on NSE XBRL
Q4 FY26Standalone12 May 2026PDF on NSE XBRL
Q3 FY26Consolidated28 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone28 Jan 2026PDF on NSE XBRL
Q2 FY26Consolidated29 Oct 2025PDF on NSE XBRL
Q2 FY26Standalone29 Oct 2025PDF on NSE XBRL
Q1 FY26Consolidated30 Jul 2025PDF on NSE XBRL
Q1 FY26Standalone30 Jul 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 28.7×21.1×
P/B5Y avg 2.20×2.16×
ROEFY26, on average equity10.3%
Net margin12.9%
Debt / equity0.11×
Revenue CAGR (3Y)–
Profit CAGR (3Y)–
EPS (TTM)₹2.12
Market cap₹20,912 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
2.16×
vs 3-point avg 2.20× (−1%)
1.94× low2.20× avg2.41× high
History points are balance-sheet dates (2025 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹12,601 Cr+14%
Net worth₹9,659 Cr+16%
Total borrowings₹1,111 Cr−21%
Cash & bank balances₹358 Cr+4%
Investments₹336 Cr
Inventories₹0 Cr
Trade receivables₹1,839 Cr+45%
Trade payables₹222 Cr+4%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Nov 24
Promoter50.9550.9550.9567.3867.3882.3982.3982.39
FII9.9910.0210.255.595.993.393.786.90
DII21.4222.2921.3614.8814.067.487.256.30
of which MF13.4514.5413.368.808.34–––
Retail14.5313.6414.029.849.395.525.293.46
Other public3.113.103.422.313.181.221.290.95
5,38,679 shareholders · NSE shareholding pattern filings.